Assignee
WELLSTAT THERAPEUTICS CORP
US·51 granted patents·18 pending applications·853 citations·filing 1995–2022
Top patents by PatentIndex Score
69 records- 0198US6924314B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Aug 2, 2005·84 cites·13 claims
- 0297US7101910B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Sep 5, 2006·66 cites·10 claims
- 0397US7041659B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 9, 2006·66 cites·3 claims
- 0497US7012071B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Mar 14, 2006·65 cites·6 claims
- 0597US6946491B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Sep 20, 2005·70 cites·19 claims
- 0697US6916848B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Jul 12, 2005·65 cites·3 claims
- 0797US6858602B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Feb 22, 2005·72 cites·9 claims
- 0896US7045541B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 16, 2006·63 cites·5 claims
- 0994US7329782B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Feb 12, 2008·34 cites·1 claims
- 1092US7547802B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Jun 16, 2009·10 cites·2 claims
- 1191US7851494B2Method for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Dec 14, 2010·9 cites·6 claims
- 1290US7863475B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Jan 4, 2011·6 cites·1 claims
- 1388US7442796B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Oct 28, 2008·25 cites·4 claims
- 1487US7361686B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 22, 2008·27 cites·5 claims
- 1586US10934284B2Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2019·Granted Mar 2, 2021·2 cites·7 claims
- 1686US7105498B2Acylated uridine and cytidine and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Sep 12, 2006·13 cites·15 claims
- 1785US6465440B2Antimutagenic compositions for treatment and prevention of photodamage to skinWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Oct 15, 2002·15 cites·30 claims
- 1884US10030015B2Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2014·Granted Jul 24, 2018·3 cites·17 claims
- 1984US9115072B2Compounds and method for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Aug 25, 2015·3 cites·14 claims
- 2084US7582619B2Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2006·Granted Sep 1, 2009·4 cites·4 claims
- 2183US7514555B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 7, 2009·16 cites·22 claims
- 2282US9133073B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Sep 15, 2015·2 cites·5 claims
- 2382US8044243B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Oct 25, 2011·5 cites·10 claims
- 2481US7947735B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted May 24, 2011·4 cites·9 claims
- 2581US7915429B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Mar 29, 2011·4 cites·8 claims
- 2680US7973052B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2009·Granted Jul 5, 2011·3 cites·6 claims
- 2780US7709459B2Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitisWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 4, 2010·13 cites·2 claims
- 2880US7615575B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Nov 10, 2009·10 cites·8 claims
- 2979US7820721B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Oct 26, 2010·3 cites·7 claims
- 3079US7115267B2Stimulator of stem cell divisionWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Oct 3, 2006·9 cites·8 claims
- 3178US7935689B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted May 3, 2011·3 cites·15 claims
- 3277US7749990B2Compositions for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2008·Granted Jul 6, 2010·2 cites·8 claims
- 3375US8022249B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2006·Granted Sep 20, 2011·2 cites·23 claims
- 3475US6858583B2Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Feb 22, 2005·2 cites·1 claims
- 3574US6743782B1Acyl deoxyribonucleoside derivatives and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2000·Granted Jun 1, 2004·3 cites·8 claims
- 3673US7169765B1Acyl deoxyribonucleoside derivatives and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2000·Granted Jan 30, 2007·3 cites·8 claims
- 3772US7645772B2Treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Jan 12, 2010·6 cites·7 claims
- 3872US6610654B2Inhibitor of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Aug 26, 2003·1 cites·1 claims
- 3968US8889724B2Tetrazole compounds for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Nov 18, 2014·1 cites·16 claims
- 4068US7906675B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Mar 15, 2011·3 cites·3 claims
- 4168US2010041147A1Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 4268US2022273688A1Treatment of Glycosylation Deficiency DiseasesWELLSTAT THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 4367US2008015209A1Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 4465USRE39573EAntimutagenic compositions for treatment and prevention of photodamage to skinWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 17, 2007·1 cites·8 claims
- 4565US2005043218A1Inhibitor of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 4659US10085957B2Benzoic acid compounds for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2016·Granted Oct 2, 2018·0 cites·10 claims
- 4759US7807654B2Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Oct 5, 2010·1 cites·36 claims
- 4859US2018298000A1Aminoquinoline compounds having anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 4958US2005203066A1Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2005·Application pending·0 cites
- 5058US2006166863A1Inhibitor and stimulator of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when WELLSTAT THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →